Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 57

1.

Activation of c-Jun N-terminal kinase (JNK) pathway by HSV-1 immediate early protein ICP0.

Diao L, Zhang B, Xuan C, Sun S, Yang K, Tang Y, Qiao W, Chen Q, Geng Y, Wang C.

Exp Cell Res. 2005 Aug 1;308(1):196-210.

PMID:
15896775
2.

Activation of c-Jun N-terminal kinase (JNK) by widely used specific p38 MAPK inhibitors SB202190 and SB203580: a MLK-3-MKK7-dependent mechanism.

Muniyappa H, Das KC.

Cell Signal. 2008 Apr;20(4):675-83. doi: 10.1016/j.cellsig.2007.12.003. Epub 2007 Dec 8.

3.
4.
5.

BX-795 inhibits HSV-1 and HSV-2 replication by blocking the JNK/p38 pathways without interfering with PDK1 activity in host cells.

Su AR, Qiu M, Li YL, Xu WT, Song SW, Wang XH, Song HY, Zheng N, Wu ZW.

Acta Pharmacol Sin. 2017 Mar;38(3):402-414. doi: 10.1038/aps.2016.160. Epub 2017 Jan 23.

6.

Hyperbaric oxygen induces VEGF expression through ERK, JNK and c-Jun/AP-1 activation in human umbilical vein endothelial cells.

Lee CC, Chen SC, Tsai SC, Wang BW, Liu YC, Lee HM, Shyu KG.

J Biomed Sci. 2006 Jan;13(1):143-56. Epub 2005 Nov 22.

PMID:
16328781
7.

TAK1-dependent activation of AP-1 and c-Jun N-terminal kinase by receptor activator of NF-kappaB.

Lee SW, Han SI, Kim HH, Lee ZH.

J Biochem Mol Biol. 2002 Jul 31;35(4):371-6.

PMID:
12296995
8.

Epstein-Barr virus latent membrane protein-1 triggers AP-1 activity via the c-Jun N-terminal kinase cascade.

Kieser A, Kilger E, Gires O, Ueffing M, Kolch W, Hammerschmidt W.

EMBO J. 1997 Nov 3;16(21):6478-85.

11.

Activation of c-Jun N-terminal kinase and activator protein 1 by receptor activator of nuclear factor kappaB.

Lee ZH, Kwack K, Kim KK, Lee SH, Kim HH.

Mol Pharmacol. 2000 Dec;58(6):1536-45.

PMID:
11093794
12.

MEKK2 regulates the coordinate activation of ERK5 and JNK in response to FGF-2 in fibroblasts.

Kesavan K, Lobel-Rice K, Sun W, Lapadat R, Webb S, Johnson GL, Garrington TP.

J Cell Physiol. 2004 Apr;199(1):140-8.

PMID:
14978743
13.

Herpes simplex virus ICP27 activation of stress kinases JNK and p38.

Hargett D, McLean T, Bachenheimer SL.

J Virol. 2005 Jul;79(13):8348-60.

14.

Herpes virus proteins ICP0 and BICP0 can activate NF-kappaB by catalyzing IkappaBalpha ubiquitination.

Diao L, Zhang B, Fan J, Gao X, Sun S, Yang K, Xin D, Jin N, Geng Y, Wang C.

Cell Signal. 2005 Feb;17(2):217-29.

PMID:
15494213
15.

Transcriptional regulation of lysophosphatidic acid-induced interleukin-8 expression and secretion by p38 MAPK and JNK in human bronchial epithelial cells.

Saatian B, Zhao Y, He D, Georas SN, Watkins T, Spannhake EW, Natarajan V.

Biochem J. 2006 Feb 1;393(Pt 3):657-68.

17.

Differentiation-associated genes regulated by TPA-induced c-Jun expression via a PKC/JNK pathway in KYSE450 cells.

Yu X, Luo A, Zhou C, Ding F, Wu M, Zhan Q, Liu Z.

Biochem Biophys Res Commun. 2006 Mar 31;342(1):286-92. Epub 2006 Feb 6.

PMID:
16480952
18.

Induced oxidative stress and activated expression of manganese superoxide dismutase during hepatitis C virus replication: role of JNK, p38 MAPK and AP-1.

Qadri I, Iwahashi M, Capasso JM, Hopken MW, Flores S, Schaack J, Simon FR.

Biochem J. 2004 Mar 15;378(Pt 3):919-28. Erratum in: Biochem J. 2004 Jul 1;381(Pt 3):951.

19.

Galloyl benzamide-based compounds modulating tumour necrosis factor α-stimulated c-Jun N-terminal kinase and p38 mitogen-activated protein kinase signalling pathways.

Leo V, Stefanachi A, Nacci C, Leonetti F, de Candia M, Carotti A, Altomare CD, Montagnani M, Cellamare S.

J Pharm Pharmacol. 2015 Oct;67(10):1380-92. doi: 10.1111/jphp.12438. Epub 2015 Jun 16.

PMID:
26078032

Supplemental Content

Support Center